Sustained Release Agent

Abstract Between 2018 and 2021, losartan was the most often recalled product (24% of total recalls) followed by metformin tablets...

Abstract Long acting injectable (LAI) suspensions represent a promising drug delivery platform, offering a number of advantages such as sustained...

Abstract Background: Pantoprazole is a widely used proton pump inhibitor that is highly unstable under acidic conditions. This limits the performance...

Abstract Background/Objectives: The development of extended-release oral dosage forms remains a complicated and time consuming process, particularly during early formulation...

Abstract The aim of this study was to develop a once-daily controlled-release (CR) apixaban (APX) formulation that enhances bioavailability through...

Abstract Nanospheres hold great promise for drug delivery but face challenges in achieving both high drug loading and sustained release....

Abstract Purpose This study was aimed to develop reservoir-type extended-release (ER) formulations resistant to alcohol-induced dose dumping (ADD) using polyvinyl acetate...

We previously demonstrated the use of near-infrared (NIR) imaging to evaluate differences in disintegration for various capsule formulations after oral...

Abstract Berberine, known as an antioxidant agent, can improve glycemic indices in animal models of diabetes; however, it is clinically...

Objective Polymeric microspheres (MS) have been developed with moderate success using aqueous emulsification (AqE) for small molecules and peptides with...